المؤلفون: García-Donas, Jesús, Martínez-Urbistondo, Diego, Velázquez Kennedy, Kyra, Villares, Paula, Barquin, Arántzazu, Domínguez, Andrea, Rodríguez-Moreno, Juan Francisco, Caro, Elena, Suárez del Villar, Rafael, Nistal-Villan, Estanislao, Yagüe, Mónica, Ortiz, Maria, Barba, Maria, Ruiz-Llorente, Sergio, Quiralte, Miguel, Zanin, Massimiliano, Rodríguez, Cristina, Navarro, Paloma, Berraondo, Pedro, Madurga, Rodrigo

المساهمون: Novartis, Instituto de Salud Carlos III, European Research Council, Ministerio de Ciencia e Innovación (España), Agencia Estatal de Investigación (España), Nafarroako Gobernua

مصطلحات موضوعية: Simvastatin, COVID19, SARS-Cov-2, Clinical trial, Cytokine storm, Ruxolitinib

وصف الملف: application/pdf

العلاقة: #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/EC/H2020/851255; info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/CEX2021-001164-M; Publisher's version; García-Donas, Jesús; Martínez-Urbistondo, Diego; Velázquez Kennedy, Kyra; Villares, Paula; Barquin, Arántzazu; Domínguez, Andrea; Rodríguez-Moreno, Juan Francisco; Caro, Elena; Suárez del Villar, Rafael; Nistal-Villan, Estanislao; Yagüe, Mónica; Ortiz, Maria; Barba, Maria; Ruiz-Llorente, Sergio; Quiralte, Miguel; Zanin, Massimiliano; Rodríguez, Cristina; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo; 2023; DataSheet_1_Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.pdf [Dataset]; Figshare; https://doi.org/10.3389/fimmu.2023.1156603.s001Test; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo; 2023; Table_1_Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.xlsx [Dataset]; Figshare; https://doi.org/10.3389/fimmu.2023.1156603.s002Test; https://doi.org/10.3389/fimmu.2023.1156603Test; Sí; Frontiers in Immunology 14: 1156603 (2023); CEX2021-001164-M; http://hdl.handle.net/10261/352169Test; http://dx.doi.org/10.13039/100004336Test; http://dx.doi.org/10.13039/501100011033Test; http://dx.doi.org/10.13039/501100000781Test; http://dx.doi.org/10.13039/501100004587Test; http://dx.doi.org/10.13039/501100004837Test; 2-s2.0-85159553059; https://api.elsevier.com/content/abstract/scopus_id/85159553059Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.115660310.13039/10000433610.13039/50110001103310.13039/50110000078110.13039/50110000458710.13039/50110000483710.3389/fimmu.2023.1156603.s00110.3389/fimmu.2023.1156603.s002Test
http://hdl.handle.net/10261/352169Test
https://api.elsevier.com/content/abstract/scopus_id/85159553059Test

المؤلفون: García-Donas, Jesús, de Velasco, Guillermo, Madurga, Rodrigo, Chamorro, Jesús, Rosero, Diana, Etxaniz, Olatz, Pérez-Gracia, Jose Luis, Pinto, Álvaro, Cacho, Diego, Barba, María, Borrega, Pablo, Lázaro, Martín, Rodriguez, Laura, Villalobos, Laura, García, Lourdes, Cuellar, Andrés, Solís-Hernández, María Pilar, González, Amalia, Pernaut, Cristina, Rodríguez-Moreno, Juan Francisco

المصدر: Clinical & Translational Oncology; Mar2024, Vol. 26 Issue 3, p732-738, 7p

المؤلفون: García-Donas, Jesús, Martínez-Urbistondo, Diego, Velázquez Kennedy, Kyra, Villares, Paula, Barquin, Arántzazu, Domínguez, Andrea, Rodríguez-Moreno, Juan Francisco, Caro, Elena, Suárez del Villar, Rafael, Nistal-Villan, Estanislao, Yagüe, Mónica, Ortiz, Maria, Barba, Maria, Ruiz-Llorente, Sergio, Quiralte, Miguel, Zanin, Massimiliano, Rodríguez, Cristina, Navarro, Paloma, Berraondo, Pedro, Madurga, Rodrigo

المساهمون: Caro, Elena, Ruiz-Llorente, Sergio, Zanin, Massimiliano

مصطلحات موضوعية: Clinical trial, COVID19, SARS-Cov-2, Cytokine storm, Ruxolitinib, Simvastatin

وصف الملف: application/vnd.ms-excel

العلاقة: García-Donas, Jesús; Martínez-Urbistondo, Diego; Velázquez Kennedy, Kyra; Villares, Paula; Barquin, Arántzazu; Domínguez, Andrea; Rodríguez-Moreno, Juan Francisco; Caro, Elena; Suárez del Villar, Rafael; Nistal-Villan, Estanislao; Yagüe, Mónica; Ortiz, Maria; Barba, Maria; Ruiz-Llorente, Sergio; Quiralte, Miguel; Zanin, Massimiliano; Rodríguez, Cristina; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution. https://doi.org/10.3389/fimmu.2023.1156603Test . http://hdl.handle.net/10261/352169Test; https://doi.org/10.3389/fimmu.2023.1156603.s002Test; Sí; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo; 2023; Table_1_Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.xlsx [Dataset]; Figshare; https://doi.org/10.3389/fimmu.2023.1156603.s002Test; http://hdl.handle.net/10261/352174Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.1156603.s002Test
https://doi.org/10.3389/fimmu.2023.1156603Test
http://hdl.handle.net/10261/352174Test

المؤلفون: García-Donas, Jesús, Martínez-Urbistondo, Diego, Velázquez Kennedy, Kyra, Villares, Paula, Barquin, Arántzazu, Domínguez, Andrea, Rodríguez-Moreno, Juan Francisco, Caro, Elena, Suárez del Villar, Rafael, Nistal-Villan, Estanislao, Yagüe, Mónica, Ortiz, Maria, Barba, Maria, Ruiz-Llorente, Sergio, Quiralte, Miguel, Zanin, Massimiliano, Rodríguez, Cristina, Navarro, Paloma, Berraondo, Pedro, Madurga, Rodrigo

المساهمون: Caro, Elena, Ruiz-Llorente, Sergio, Zanin, Massimiliano

مصطلحات موضوعية: Clinical trial, COVID19, SARS-Cov-2, Cytokine storm, Ruxolitinib, Simvastatin

وصف الملف: application/pdf

العلاقة: García-Donas, Jesús; Martínez-Urbistondo, Diego; Velázquez Kennedy, Kyra; Villares, Paula; Barquin, Arántzazu; Domínguez, Andrea; Rodríguez-Moreno, Juan Francisco; Caro, Elena; Suárez del Villar, Rafael; Nistal-Villan, Estanislao; Yagüe, Mónica; Ortiz, Maria; Barba, Maria; Ruiz-Llorente, Sergio; Quiralte, Miguel; Zanin, Massimiliano; Rodríguez, Cristina; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution. https://doi.org/10.3389/fimmu.2023.1156603Test . http://hdl.handle.net/10261/352169Test; https://doi.org/10.3389/fimmu.2023.1156603.s001Test; Sí; Navarro, Paloma; Berraondo, Pedro; Madurga, Rodrigo; 2023; DataSheet_1_Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.pdf [Dataset]; Figshare; https://doi.org/10.3389/fimmu.2023.1156603.s001Test; http://hdl.handle.net/10261/352172Test

الإتاحة: https://doi.org/10.3389/fimmu.2023.1156603.s001Test
https://doi.org/10.3389/fimmu.2023.1156603Test
http://hdl.handle.net/10261/352172Test